Blockchain Registration Transaction Record

New Study Shows Cardio Diagnostics NASDAQ CDIO PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually

Cardio Diagnostics NASDAQ CDIO PrecisionCHD test results, budget impact study, cost savings, coronary heart disease detection, CPT code, Vizient contract

Heart disease remains the leading cause of death among Americans, and the barriers to obtaining early cardiovascular care could lead to increased prevalence and costs. PrecisionCHD offers a more cost-efficient, less resource-intensive, and highly scalable alternative for initial CHD detection testing, potentially revolutionizing how coronary heart disease is diagnosed and managed. The study's findings have the potential to increase access to care, improve outcomes for patients with CHD, and drive value for healthcare stakeholders.